Tag: Motley Fool

On Friday, the S&P/ASX 200 Index (ASX: XJO) finished the week in a positive fashion. The benchmark index rose 0.6% to 7,015.6 points.

Will the market be able to build on this on Monday? Here are five things to watch:

ASX 200 expected to edge lower

The Australian share market looks set to start the week with a small decline following a mixed night on Wall Street on Friday. According to the latest SPI futures, the ASX 200 is expected to open the day 7 points or 0.1% lower this morning. On Wall Street, the Dow Jones was up 0.2%, the S&P 500 fell 0.15%, and the NASDAQ dropped 0.5%.

Oil prices rebound

Energy producers Santos Ltd (ASX: STO) and Woodside Energy Group Ltd (ASX: WDS) could have a decent start to the week after oil prices pushed higher on Friday. According to Bloomberg, the WTI crude oil price rose 0.5% to US$89.01 a barrel and the Brent crude oil price climbed 0.85% to US$94.92 a barrel. Oil prices rebounded from their lowest levels since February after concerns over supply shortages offset expected declines in fuel demand.

Suncorp results

The Suncorp Group Ltd (ASX: SUN) share price will be on watch on Monday when the insurance giant releases its full year results. According to CommSec, the market is expecting the company to report a net profit after tax of $699 million for FY 2022. This is expected to underpin a full year fully franked 23 cents per share dividend.

Gold price slides

Gold miners Newcrest Mining Limited (ASX: NCM) and Northern Star Resources Ltd (ASX: NST) could have a poor start to the week after the gold price tumbled on Friday night. According to CNBC, the spot gold price was down 0.8% to US$1,792.40 an ounce. A strong US jobs report eased recession fears and reduced the appeal of the safe haven asset.

Aurizon results

The Aurizon Holdings Ltd (ASX: AZJ) share price will be in focus on Monday when the rail freight operator releases its full year results. The market is expecting the company to report a net profit after tax of $513 million and a full year dividend of 10.9 cents.

The post 5 things to watch on the ASX 200 on Monday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Is the VAS dividend yield bigger than an ASX 200 index fund?
• What goes up when the share market crashes?
• 5 proven investment strategies you can use to ride out a recession
• Sick of high petrol prices? Then buy this ASX share: analyst
• The iron ore price has slumped 10% in 5 days. Here’s how ASX 200 mining shares have responded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Aurizon Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Ljk2zVF

The Telix Pharmaceuticals Ltd (ASX: TLX) share price finished the session on Friday up 0.52% to $7.79. Over the past month, the ASX healthcare share has risen in value by an extraordinary 50.1%.

Contributing to this gain was the investor response to the company’s June quarter report on 21 July.

As my Fool colleague Zach reported, it was the cancer diagnostic and treatment business’s “first commercial quarter”, during which time they launched the Illuccix prostate cancer treatment in the US.

The Telix share price rose by 5.51% on the day of the news.

Fund managers backing Telix share price for growth

Telix treatment technology delivers radiation directly to tumours by putting radiopharmaceuticals into the bloodstream to find and target the cancers.

Illuccix is designed to find prostate cancers in high-risk men before surgery. It is also used to detect prostate-specific antigens (PSAs) in men deemed at risk of the cancer returning after surgery.

According to reporting in the Australian Financial Review (AFR), a bunch of professional fund managers are backing the Telix share price for growth.

They include Antares Capital Broadcap Australian Equities Fund, Platinum Asset Management, Perennial Partners, Fidelity, Acorn Capital, and Wilson Asset Management.

Jefferies, Wilsons, Taylor Collison, and Bell Potter all rate Telix a buy with share price valuations between $8.50 and $10.70.

Maiden profit ahead for Telix

According to the article, Wilsons expects Telix to make a $32.8 million loss in FY23 before a maiden profit of $7.7 million in fiscal 2024.

Healthcare analyst Andrew Hamilton from the Antares Capital Broadcap Australian Equities Fund said:

We still think [Telix] shares have further upside. I think that first [June] quarter of commercial sales in Illuccix show it’s a great product. It entered the market and got very good awareness of PSMA (prostate-specific membrane antigen) imaging. They’ve done a great job on execution, manufacturing, logistics, awareness and the commercial pipeline. For it to all work is a fantastic effort, we expect sales will accelerate.

Platinum Asset Management bought Telix at its initial public offering (IPO) in October 2017. At the time, Telix was selling at a price of 65 cents per share.

Platanium Healthcare analyst Dr Bianca Ogden said:

We’ve always been fans of using imaging as a diagnostic. Because it’s the easiest way to visualise something. We liked the idea when Telix started out to do this properly and consolidate the industry. And we’ve always invested in the targeted radiotherapy industry as a whole.

Is Illuccix approved for prostate cancer therapy in Australia?

Yes — the Therapeutic Goods Administration (TGA) gave commercial approval for Illuccix in November 2021. It’s the first prostate-specific radioactive imaging agent to get approval here.

The Telix share price gained 8.13% on the day of the announcement.

According to the article, Telix has another treatment for prostate cancer. It also has treatments for brain cancer and renal cancer that are in Phase 2 or Phase 3 clinical trial stage.

Hamilton said:

From a valuation perspective the biggest thing in their locker is their prostate cancer therapy drug, TLX 591. That’s just at the start of Phase 3 trials, so it’s obviously a number of years away. But it still has global leadership in an emerging field, so it’s not a one trick pony. It has a deep pipeline, and we think other products coming behind look good.

The Telix share price is down 4.7% in 2022. This compares to an 8.5% dip in the S&P/ASX All Ordinaries Index (ASX: XAO).

The post Up 50% in a month: Why all these fundies predict more greatness for the Telix Pharmaceuticals share price appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Why A2 Milk, Qualitas, Telix, and Ventia shares are pushing higher today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/qaghSbd

The Australian share market is home to a number of companies with strong long term growth potential.

Two that could be particularly well-placed for growth are listed below. Here’s what you need to know about these ASX shares:

Allkem Ltd (ASX: AKE)

The first ASX growth share to look at is lithium miner Allkem. It owns a collection of high-quality assets including Olaroz, Mt Cattlin, and the Sal de Vida brine project.

Thanks to sky high lithium prices, Allkem has delivered significant sales and profit growth in FY 2022. Pleasingly, this looks likely to continue in FY 2023 thanks to ongoing strength in prices, the end of older supply contracts at much lower prices, and increasing production.

And the latter isn’t about to stop any time soon. Management is aiming to triple its production by 2026 and ultimately maintain a 10% share of global supply in the future.

Morgans is very bullish on Allkem. Its analysts have an add rating and $16.72 price target on its shares.

Domino’s Pizza Enterprises Ltd (ASX: DMP)

Another ASX growth share that could be in the buy zone is Domino’s.

It is one of the largest pizza chain operators in the world with almost 900 stores across ANZ region, over 1,300 stores in Europe, and over 1,000 stores in Asia.

But management isn’t stopping there. It has set itself a target of 6,650 stores by 2033, which is over double its current footprint. If Domino’s delivers on this and continues delivering same store sales growth, this will bode well for its growth over the next decade.

And while the company is going through a difficult period at the moment, the team at Citi believe investors should be patient and focus on its long term growth opportunity.

Citi has a buy rating and $92.95 price target on Domino’s shares.

The post 2 excellent ASX growth shares to buy – experts appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Experts name 2 beaten down ASX shares that could be going cheap
• Top brokers say Domino’s share price has loads of extra topping in it, here’s why
• Here are the top 10 ASX 200 shares today
• Why is the Allkem share price leaping 5% on Monday?
• Top brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Dominos Pizza Enterprises Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/xWHe6wz

The Vanguard Australian Shares Index ETF (ASX: VAS) has the distinction of being the most popular exchange-traded fund (ETF) on the ASX. It’s also a rather unique ETF in that it remains the only index fund on the ASX boards that tracks the S&P/ASX 300 Index (ASX: XKO).

The ASX 300 is similar to the far more popular and widely-tracked S&P/ASX 200 Index (ASX: XJO). Many ETFs on the ASX track the ASX 200, but only VAS mirrors the ASX 300.

The ASX 200 and ASX 300 both track the 200 largest shares on the ASX by market capitalisation. But the ASX 300 (you guessed it) adds another 100 of the smaller shares on the ASX. Thus, this gives VAS a slightly larger and more diverse underlying portfolio of ASX shares.

Here at the Fool, we’ve looked at how this has given VAS a performance edge over other ASX 200 index funds before. But today, let’s see how the dividends from the Vanguard Australian Shares Index ETF stack up against an ASX 200 ETF.

VAS vs ASX 200 ETFs: Whose dividends are bigger?

So, like most index funds, VAS paid a dividend distribution every quarter. Its last four distributions have totalled approximately $6.26 in dividend distributions per unit. On the current VAS unit price of $87.13, this gives the ETF a trailing dividend distribution yield of 7.18%.

Let’s now compare that trailing yield to a popular ASX 200 index fund in the iShares Core S&P/ASX 200 ETF (ASX: IOZ).

So, like VAS, IOZ also pays out quarterly distributions. Its last four payments amounted to approximately $1.61 per unit. On the iShares ASX 200 ETF’s last unit price of $28.27, this grants the ETF a trailing yield of 5.7%.

So VAS has come out on top in terms of yield over the past 12 months, at least against IOZ. But let’s look at another ASX 200 ETF, just to make sure.

This time, we’ll turn to the SPDR S&P/ASX 200 ETF (ASX: STW), one of the oldest index funds on the ASX. So again, we have four dividend distributions to tally up, which in this case gives us a total of $4.18 in distribution per unit over the past 12 months.

On the current unit price, this gives us a trailing yield of 6.58% on STW’s last pricing.

The differing yields between these various ETFs come down to a number of different factors. But what is clear is that the Vanguard Australian Shares Index ETF certainly comes out on top when assessing dividend income over the past 12 months.

The post Is the VAS dividend yield bigger than an ASX 200 index fund? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What goes up when the share market crashes?
• 5 proven investment strategies you can use to ride out a recession
• The iron ore price has slumped 10% in 5 days. Here’s how ASX 200 mining shares have responded.
• Here are the top 10 ASX 200 shares today
• Here are the 3 most heavily traded ASX 200 shares on Friday

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/QTIn4No

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.

Here’s why brokers think investors ought to buy them next week:

Coles Group Ltd (ASX: COL)

According to a note out of Citi, its analysts have retained their buy rating and lifted their price target on this supermarket giant’s shares to $21.00. Citi has upgraded its earnings forecasts to reflect an expected boost to the company’s sales from inflation. The broker also feels that Coles’ shares are trading on attractive multiples compared to historical averages. The Coles share price ended the week at $18.94.

Objective Corporation Limited (ASX: OCL)

A note out of Goldman Sachs reveals that its analysts have upgraded this software company’s shares to a buy rating with an $18.90 price target. The broker made the move partly on valuation grounds following a de-rating in recent months. In addition, Goldman has increased conviction around Objective’s growth outlook as new products scale. It expects this to support an earnings per share compound annual growth rate of greater than 20% between FY 2022 to FY 2025. The Objective share price was fetching $16.61 at Friday’s close.

Pilbara Minerals Ltd (ASX: PLS)

Analysts at Macquarie have retained their outperform rating on this lithium miner’s shares with a trimmed price target of $4.00. The broker has visited the company’s Pilgangoora lithium-tantalum project and was pleased with what it saw. It believes that recent improvements suggest there’s potential for better than expected production at Pilgan and Ngungaju. Outside this, the broker is a big fan due to the significant free cash flow its operations are generating at spot lithium prices. The Pilbara Minerals share price ended the week at $2.87.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the Pilbara Minerals share price having such a strong end to the week?
• Here are the 3 most heavily traded ASX 200 shares on Friday
• ASX lithium shares facing ‘insatiable’ demand amid global funding gap
• Goldman Sachs just slapped a buy rating on this ASX tech share
• Here are the 3 most heavily traded ASX 200 shares on Thursday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Objective Corporation Limited. The Motley Fool Australia has positions in and has recommended COLESGROUP DEF SET. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/W2HDIKn

If you’re on the lookout for ASX 200 shares to add to your portfolio, then the two listed below could be worth a closer look.

Here’s what you need to know about these shares right now:

Altium Limited (ASX: ALU)

The first ASX 200 share to look at is Altium. It is an electronic design software provider that is best-known for its industry-leading Altium Designer and Altium 365 platforms. The company also has a parts search engine called Octopart that is performing exceptionally well thanks to supply chain disruption.

All in all, Altium appears well-placed for growth over the next decade. Particularly given the growing internet of things and artificial intelligence markets, which are driving strong demand for electronic design software.

Bell Potter currently has a buy rating and $34.00 price target on Altium’s shares. Its analysts “believe the company is on track to achieve its FY22 guidance and expect much better subscriber growth in 2HFY22 relative to 1HFY22.”

Xero Limited (ASX: XRO)

Another ASX 200 share that could be a top option for investors next week is Xero.

It is a cloud accounting platform provider with ~3.3 million subscribers globally. And while this is a large number and Xero is generating material recurring revenue from these subscribers, it is still only a fraction of its addressable market. Management estimates that to be 45 million subscribers, which means it has only capture 7.3% of its market so far.

Goldman Sachs is a big fan of Xero. Its analysts believe the company is “well-placed to navigate this uncertainty given the stickiness & importance of its software.”

The broker has a buy rating and $113.00 price target on Xero’s shares.

The post 2 stellar ASX 200 shares that brokers rate as buys appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What’s happening with the Xero share price at the end of a strong week?
• Why are ASX 200 tech shares having such a stellar run today?
• Experts name 2 beaten down ASX shares that could be going cheap
• How did the Altium share price respond last earnings season?
• Broker gives its verdict on the Xero share price following new product launch

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Altium and CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ko1HgSG

Rising interest rates both in Australia and the US mean consumers have less money to spend on constructing new homes or even renovating existing ones.

It’s this logic that’s seen the share price for construction materials provider James Hardie Industries plc (ASX: JHX) drop 36% so far this year.

Fairmont Equities managing director Michael Gable agreed in a research note that the market was nervous about the business outlook.

“The weakness in housing has the potential to significantly impact James Hardie’s Repair and Remodel (R&R) segment, to the point that earnings weakness from the R&R segment are likely to overshadow the earnings benefit from internal initiatives.”

However, he thought this was overemphasised and that the stock actually represented excellent value for buying right now.

Repair and remodel business could be stronger than the market expects

Firstly, Gable pointed out that the R&R business is, by nature, pretty stable through different parts of the economic cycle.

“In the event of a mild recession, the R&R segment should prove resilient, given its growing portfolio of relevant products, a strong channel position and brand and marketing.”

Moreover the current rising interest rate environment is significantly different to the typical period when loan repayments are rising.

“Work-from-home trends post-COVID are still driving activity, supported by home equity,” said Gable.

“Home equity is at an all-time high buoyed by recent strong price gains and home equity loan balances remain low by historical standards.”

Even though James Hardie originated in Australia, these days North America is a dominant revenue drive.

And home owners are simply in a different situation to Australian mortgage holders.

“While there are numerous pressures on disposable incomes, the fact that 90%+ of mortgages in the US are 30-year fixed, the feed-through of higher rates is somewhat less systemic in their impact.”

Two potential stock price catalysts

So after the sell-off this year, James Hardie is a bargain buy at the moment, in Gable’s opinion.

“With expectations for flat-to-declining EPS growth in FY24, the shares are trading at a significant discount to its recent trading history,” he said.

“Having said that, James Hardie’s overweight to R&R vs new construction will also help brace earnings, given R&R downturns are shorter and not as severe as new home construction.”

The company is due to release its 2023 first quarter results on 16 August and will host an Investor Day next month.

Gable has flagged a couple of potential catalysts that could come out of those days:

• Greenfield expansion in US and Europe
• Update on the search for a new chief executive officer 

James Hardie shares closed Friday at $35.98.

The post Buy this ASX share now before it reports this month: expert appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 ASX 300 shares this fundie has been buying at bargain prices
• 2 ASX shares we just bought that everyone’s underestimating: fund
• Chicken and chips: Experts name 3 ASX shares to buy right now
• A high-quality ASX 200 share to capitalise on market volatility: fundie

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/ZT9PqIn

With the cost of living continuing to rise, income investors may want to look at the dividend shares listed below for a boost to their income.

Here’s why these two ASX dividend shares have been rated as buys:

Charter Hall Retail REIT (ASX: CQR)

The first dividend share to look at is the Charter Hall Retail REIT. This REIT provides investors with exposure primarily to the supermarket anchored neighbourhood and sub-regional shopping centre markets in Australia.

The team at Macquarie are positive on the company. Last week the broker retained its outperform rating with an improved price target of $4.23.

It was pleased to see the company announce the acquisition of a portfolio of 18 Gull service stations in New Zealand and expand its partnership with Ampol Ltd (ASX: ALD).

In respect to dividends, the broker is expecting dividends per share to 24.5 cents in FY 2022 and 23.3 cents in FY 2023. Based on the current Charter Hall Retail REIT share price of $4.06, this implies potential yields of 6% and 5.7%, respectively.

Mineral Resources Limited (ASX: MIN)

Another ASX dividend share to look at is Mineral Resources. This mining and mining services company could be a top option for income investors that aren’t averse to investing in the resources sector.

Goldman Sachs is very positive on the company and has a buy rating and $65.80 price target.

Its analysts like Mineral Resources due to its “compelling near term volume and earnings growth” and “attractive valuation” at ~0.9 times NAV and ~4 times FY 2023 EBITDA.

As for dividends, Goldman is forecasting fully franked dividends of 67 cents per share in FY 2022 and then 296 cents per share in FY 2023. Based on the latest Mineral Resources share price of $57.65, this will mean yields of 1.1% and 5.1%, respectively.

The post Analysts name 2 ASX dividend shares to buy next week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Buy this ASX share for its ‘undervalued’ lithium business: expert
• Top brokers name 3 ASX shares to buy next week
• Brokers name 3 ASX shares to buy today
• Here are the top 10 ASX 200 shares today
• Mineral Resources share price on watch following Q4 update

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/4V6byJd

Are you interested in boosting your portfolio with some exchange traded funds (ETFs)?

If you are, then you may want to look at the highly rated ETFs listed below. Here’s what you need to know about them:

iShares S&P 500 ETF (ASX: IVV)

The first ETF for investors to look at is the iShares S&P 500 ETF. This ETF aims to provide investors with the performance of the famous S&P 500 Index before fees and expenses. This index is home to the top 500 U.S. stocks.

BlackRock, which runs iShares, believes this can be used by Australian investors to diversify internationally and seek long-term growth opportunities for a portfolio.

The companies included in the fund need no introduction. Among the ETF’s largest holdings are the likes of Amazon, Apple, Berkshire Hathaway, Facebook, JP Morgan, Johnson & Johnson, Microsoft, and Tesla.

Since this time in 2017, the iShares S&P 500 ETF would have turned a $10,000 investment into almost $19,000.

Vanguard MSCI Index International Shares ETF (ASX: VGS)

Another ETF for investors to look at is the Vanguard MSCI Index International Shares ETF. This ETF provides investors with exposure to even more shares than the iShares S&P 500 ETF.

The numbers change periodically as stocks are added and removed from the ETF. But generally speaking, there are approximately 1,500 of the largest listed companies from major developed countries.

Vanguard, which run the ETF, notes that the ETF offers low-cost access to a broadly diversified range of securities that allow investors to benefit from the long-term growth potential of the global economy. The fund manager appears to believe this makes it a good option for buy and hold investors seeking long-term capital growth, some income, and international diversification.

Among the companies included in the fund are giant such as Apple, Microsoft, Nestle, NVIDIA, Procter & Gamble, Tesla, and Visa.

Over the last five years, the Vanguard MSCI Index International Shares ETF would have turned a $10,000 investment into over $16,000.

The post 2 quality ETFs for ASX investors to buy next week appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 things I love about the iShares S&P 500 ETF right now
• I rate these top ASX growth shares as buys in August
• 3 wonderful ETFs for ASX investors to buy today
• Is the Vanguard VGS ETF a good idea for dividends?
• 3 quality ETFs for ASX investors in July

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Vanguard MSCI Index International Shares ETF. The Motley Fool Australia has recommended Vanguard MSCI Index International Shares ETF and iShares Trust – iShares Core S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/vOy5oaA

If you’re an income investor searching for new dividend shares to buy, it could be worth checking out the two listed below.

Here’s why they are rated as buys right now:

Adairs Ltd (ASX: ADH)

The first ASX dividend share that could be a buy is Adairs. It is the leading furniture and homewares retailer behind the Focus on Furniture, Mocka, and eponymous Adairs brands.

The retailer is having a bit of a tough time this year and is expected to post a sharp decline in profits in FY 2022. This has been driven by significant COVID related disruptions across its operations.

However, management remains positive on the future. It highlights that “these [disruptions] should not be recurring in the medium term and the underlying business continues to perform well.”

This view is shared with the analysts at Wilson, which have an overweight rating and $4.50 price target on the company’s shares.

In addition, the broker is forecasting fully franked dividends per share of 19 cents per share in FY 2022 and 31 cents per share in FY 2023. Based on the current Adairs share price of $2.48, this will mean yields of 7.7% and 12.5%, respectively.

Westpac Banking Corp (ASX: WBC)

Another ASX dividend share that could be a quality option for income investors next week is banking giant Westpac.

It has recently been tipped as a buy by analysts at Goldman Sachs with a $26.12 price target.

The broker believes Westpac provides strong leverage to rising rates. It expects the bank to benefit from the relative lack of domestic deposit repricing that has been seen to date following recent rates cash rate rises.

As for dividends, the broker is forecasting fully franked dividends per share of 123 cents in FY 2022 and 135 in FY 2023. Based on the current Westpac share price of $21.96, this will mean yields of 5.6% and 6.15%, respectively, over the next two years.

The post 2 ASX dividend shares that experts rate as buys appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Can Westpac shares deliver a competitive dividend yield and 20% upside in FY23?
• Broker says Westpac share price ‘offers the most upside of the banks’
• How are ASX 200 bank shares responding to the RBA rate increase?
• 5 things to watch on the ASX 200 on Tuesday
• Will the RBA increase rates today?

Motley Fool contributor James Mickleboro has positions in Westpac Banking Corporation. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ADAIRS FPO. The Motley Fool Australia has positions in and has recommended ADAIRS FPO. The Motley Fool Australia has recommended Westpac Banking Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/uFQpqNt